Skip to main content

LizarBio Therapeutics

Dover, United States

Pre Clinical Stage Company working with Advanced Cell Therapies to cure incurable diseases using cells.

$525K raised
Mar 2022
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about LizarBio Therapeutics

How much funding has LizarBio Therapeutics raised?
LizarBio Therapeutics has raised $525K in total funding. The most recent round was Seed. The last funding was announced in March 2022.
Who are LizarBio Therapeutics's investors?
LizarBio Therapeutics's investors include SOSV, SOSV SF & NY (Fka IndieBio), Kria, Libbs Farmacêutica.
Where is LizarBio Therapeutics headquartered?
LizarBio Therapeutics is headquartered in Dover, United States.
What does LizarBio Therapeutics do?
Pre Clinical Stage Company working with Advanced Cell Therapies to cure incurable diseases using cells.
What stage is LizarBio Therapeutics at?
LizarBio Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"LizarBio Therapeutics — Funding & Investors." VCBacked, March 7, 2022, https://www.vcbacked.co/company/lizarbio-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). LizarBio Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lizarbio-therapeutics
Wikipedia (cite web)
{{cite web |title=LizarBio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lizarbio-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .